Efficacy And Safety Propel The Convalescent Plasma Therapy Market: A Key Driver Powering Convalescent Plasma Therapy Market Growth In 2025

The Convalescent Plasma Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_
_x000D_
What Is the Current Convalescent Plasma Therapy Market Size and Its Estimated Growth Rate?_x000D_
The convalescent plasma therapy market has grown quickly in recent years and is expected to move from $0.05 billion in 2024 to $0.06 billion in 2025, showing a CAGR of 11.4%. Key contributors to earlier growth include infectious outbreaks, advances in immunotherapy, regulatory approvals, patient pool availability, and heightened awareness._x000D_
_x000D_
The convalescent plasma therapy market is expected to see rapid growth in the coming years. It will reach $0.09 billion by 2029, growing at a CAGR of 13.7%. The growth is driven by evolving pathogens, the development of immunotherapies, regulatory frameworks, and global health preparedness efforts. Key trends include standardized collection processes, targeted plasma components, personalized treatment approaches, and research into long-term effects._x000D_
_x000D_
Purchase the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3233_x000D_
_x000D_
How Are Emerging Segments Shaping the Convalescent Plasma Therapy Market Landscape?_x000D_
The convalescent plasma therapy market covered in this report is segmented -_x000D_
_x000D_
1) By Antibody type: IgM, IgG, IgA_x000D_
2) By Application: Prophylaxis, Treatment_x000D_
3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products_x000D_
2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products_x000D_
3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products_x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp_x000D_
_x000D_
Which Growth Factors Are Influencing Convalescent Plasma Therapy Market Expansion?_x000D_
The effectiveness and safety of convalescent plasma therapy (CPT) for COVID-19 patients are expected to drive the growth of the global convalescent plasma therapy market. Studies, such as one conducted by Houston Methodist hospital in 2022, confirmed the safety and 76% recovery rate of CPT. Positive outcomes in previous infectious disease outbreaks further support the market's growth._x000D_
_x000D_
Who Are the Dominant Players Across Different Convalescent Plasma Therapy Market Segments?_x000D_
Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank_x000D_
_x000D_
What Are the Latest Developing Trends in the Convalescent Plasma Therapy Market?_x000D_
The advancement of antibody-based immunotherapy for COVID-19 is creating new opportunities for the convalescent plasma therapy market. This therapy uses antibodies from recovered patients to boost the immunity of recipients. Companies are initiating collaborations and investments in such therapies. For example, in August 2023, Regeneron Pharmaceuticals Inc. partnered with BARDA to support the development and approval of next-generation monoclonal antibody treatments under the HHS-led Project NextGen. Since this therapy involves antibody use, it supports the growing focus on antibody-based COVID-19 interventions, further driving market growth._x000D_
_x000D_
Get the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report_x000D_
_x000D_
Which Geographic Regions Are Expected to Dominate the Convalescent Plasma Therapy Market in the Coming Years?_x000D_
North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
Frequently Asked Questions:_x000D_
1. What Is the Market Size and Growth Rate of the Convalescent Plasma Therapy Market?_x000D_
2. What is the CAGR expected in the Convalescent Plasma Therapy Market?_x000D_
3. What Are the Key Innovations Transforming the Convalescent Plasma Therapy Industry?_x000D_
4. Which Region Is Leading the Convalescent Plasma Therapy Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.